Younger patients with Metastatic Colorectal Cancer (that has spread to other parts of the body) represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they are at greater risk of death than other age groups, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday). An analysis of 20,034 patients in 24 phase III clinical trials ...
via Medindia Health News More READ
No comments:
Post a Comment